Protein and RNA analysis could improve infection risk assessment in CLL patients on immune-based therapies. Inflammatory transcriptome profiles and protein responses to PMA stimulation were linked to ...

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) regarding characterization and treatment of central ...

Please provide your email address to receive an email when new articles are posted on . Mistrust is a key barrier when discussing tumor genomic profiling with African American patients with cancer.

Precision therapies and immunotherapies have revolutionized cancer care, with novel genomic biomarker-associated therapies being introduced into clinical practice rapidly, resulting in notable gains ...

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers ...

NCCN now endorses CSF-based profiling for biopsy-infeasible HGG/GBM to enable molecular characterization required for ...

Avoiding unnecessary biopsy: Development of a predictive calculator to identify non-prostate cancer in patients with Prostate Imaging Reporting and Data System category ≥ 4 lesions. This is an ASCO ...

Identifying the AbnormalWhen considering risk in the healthcare environment – risk involving patient privacy and protected health information – profiling is critical and represents a key component of ...